You searched for "elective"
Birmingham Neuro-Ophthalmology: The Birmingham Afferent Course
16 January 2025
Objective: The aim is to review the physiology and the pathology of optic nerve disorders. The course is aimed at ophthalmologists, neurologists and orthoptists of all grades. It will be of value to those preparing for exams or refreshing their...
Birmingham Neuro-Ophthalmology: The Birmingham Efferent Course
17 January 2025
Objective:The aim is to review the physiology and the pathology of eye movements. The course is aimed at ophthalmologists, neurologists and orthoptists of all grades. It will be of value to those preparing for exams or refreshing their neuro-ophthalmology knowledge....
2018 update on intravitreal injections
1 December 2018
| Sofia Rokerya
|
EYE - Vitreo-Retinal
In this review article the authors have highlighted the standardised and structured approach to intravitreal injections (IVI) by examining the recent evidence-based literature. IVI is the most commonly performed procedure worldwide with low potential risk of endophthalmitis. IOP spikes are...
Considerations in the management of retinal disorders
1 October 2017
| Rod McNeil
|
EYE - Vitreo-Retinal
Vision research presentations and publications explore practice considerations in the management of AMD and diabetic retinopathy. Over the past two decades in Europe there has been a decreasing prevalence of age-related macular degeneration (AMD) and an improvement in visual acuity...
Refined glaucoma referral practice offers prospect of improved capacity and expanded role for primary eye care professionals
1 February 2018
| Rod McNeil
|
EYE - Glaucoma
Glaucoma is the most frequent cause of irreversible blindness worldwide and the second leading cause of blindness in the UK [1,2]. The global prevalence of glaucoma in 2010 was approximately 3.5% for people aged 40-80 years, according to Jonas et...
Aqueous humour cytokine levels in PCV and nAMD
1 April 2015
| Bheemanagouda Patil
|
EYE - Vitreo-Retinal
This study looks into the possible roles of various cytokines or growth factors in the pathogenesis of exudative age-related macular degeneration (AMD) by comparing aqueous levels of 14 cytokines between eyes with polypoidal choroidal vasculopathy (PCV) and those with neovascular...
Hype or helpful: ChatGPT
5 June 2023
| David Haider
|
EYE - General
It would have been hard to miss all the attention chatbots have received over the last few months. Whilst ChatGPT is easily the most well-known example of the large language models that have become so widespread of late, artificial intelligence...
A look into the IOL space
Advances in the design and performance of intraocular lenses (IOLs) continue to be driven by demand for better outcomes, presbyopia correction and spectacle independence, alongside a better understanding of the dynamics of the crystalline lens, newer theories of accommodation and...Sharing best practice and landmark evidence in glaucoma care
Evolving technology, best practice and landmark evidence in glaucoma care were reviewed by an international expert faculty in session presentations and debates during the 11th Moorfields International Glaucoma Symposium 2019. The authors were meeting chairs and provide an overview of...New IGA research award
11 February 2020
Applications open for new £50,000 glaucoma research Allied Healthcare professionals award The International Glaucoma Association (IGA) announces call for applications for new £50,000 Allied Healthcare professionals award for glaucoma research. The new award, which opened on 21 October 2019 and...
Fight for Sight continues to promote eye research
7 April 2020
Eye research charity Fight for Sight has announced its latest project funding and its plans for continuing its efforts to advance eye research in the current global health crisis and beyond.
CBM launches the Light up Lives appeal
18 February 2021
CBM has launched a fundraising appeal to improve access to sight-saving treatment in Zimbabwe, and until 20 May all public donations will be doubled by the UK government.